Effect of Dexrazoxane and Amifostine on the Vertebral Bone Quality of Doxorubicin Treated Male Rats

Doxorubicin (DOX) is widely used in combination cocktails for treatment of childhood hematological cancers and solid tumors. A major factor limiting DOX usage is DOX-induced cardiotoxicity. However, it is not known whether protectants like dexrazoxane (DXR) and amifostine (AMF) can prevent DOX-media...

Descripción completa

Detalles Bibliográficos
Autores principales: Mwale, F, Marguier, G, Ouellet, J.A, Petit, A, Epure, L.M, Antoniou, J, Chalifour, L.E
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687116/
https://www.ncbi.nlm.nih.gov/pubmed/19478935
http://dx.doi.org/10.2174/1874325000802010115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687116/
https://www.ncbi.nlm.nih.gov/pubmed/19478935
http://dx.doi.org/10.2174/1874325000802010115

Ejemplares similares